Distinct loiasis infection states and associated clinical and hematological manifestations in patients from Gabon

Background Loiasis–a filarial disease endemic in Central and West Africa–is increasingly recognized as significant individual and public health concern. While the understanding of the disease characteristics remains limited, significant morbidity and excess mortality have been demonstrated. Here, we characterize clinical and hematological findings in a large cohort from Gabon. Methods Loiasis-related clinical manifestations and microfilaremia, hemoglobin and differential blood counts were recorded prospectively during a cross-sectional survey. For analysis, participants were categorized into distinct infection states by the diagnostic criteria of eye worm history and microfilaremia. Results Analysis of data from 1,232 individuals showed that occurrence of clinical and hematological findings differed significantly between the infection states. Eye worm positivity was associated with a wide range of clinical manifestations while microfilaremia by itself was not. Loa loa infection was associated with presence of eosinophilia and absolute eosinophil counts were associated with extent of microfilaremia (p-adj. = 0.012, ß-estimate:0.17[0.04–0.31]). Conclusions Loiasis is a complex disease, causing different disease manifestations in patients from endemic regions. The consequences for the affected individuals or populations as well as the pathophysiological consequences of correlating eosinophilia are largely unknown. High-quality research on loiasis should be fostered to improve patient care and understanding of the disease.

[1]  K. Jacobsen,et al.  A call for loiasis to be added to the WHO list of neglected tropical diseases. , 2022, The Lancet. Infectious diseases.

[2]  F. Gobbi,et al.  Spleen nodules in Loa loa infection: re-emerging knowledge and future perspectives. , 2022, The Lancet. Infectious diseases.

[3]  M. Ramharter,et al.  The Supposedly Innocuous Eye Worm: Or, What Could Make You Put Chili in Your Eye? , 2021, The American journal of tropical medicine and hygiene.

[4]  B. Mordmüller,et al.  Molecular epidemiology of Mansonella species in Gabon. , 2020, The Journal of infectious diseases.

[5]  S. Agnandji,et al.  Burden of disease in Gabon caused by loiasis: a cross-sectional survey. , 2020, The Lancet. Infectious diseases.

[6]  S. Pion,et al.  Uncovering the burden of loiasis: first estimates from Gabon. , 2020, The Lancet. Infectious diseases.

[7]  T. Nutman,et al.  Infection-associated Immune Perturbations Resolve One Year Following Treatment for Loa loa. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  C. Whittaker,et al.  Atypical Clinical Manifestations of Loiasis and Their Relevance for Endemic Populations , 2019, Open forum infectious diseases.

[9]  T. Nutman,et al.  Immune Responses to Helminth Infection , 2019, Clinical Immunology.

[10]  J. Akue,et al.  Loa loa infection detection using biomarkers: current perspectives , 2018, Research and reports in tropical medicine.

[11]  C. Whittaker,et al.  The Population Biology and Transmission Dynamics of Loa loa. , 2018, Trends in parasitology.

[12]  B. Mordmüller,et al.  Behavioural and clinical predictors for Loiasis , 2018, Journal of global health.

[13]  M. Boussinesq,et al.  Familial Aggregation and Heritability of Loa loa Microfilaremia , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  M. Boussinesq,et al.  Excess mortality associated with loiasis: a retrospective population-based cohort study. , 2017, The Lancet. Infectious diseases.

[15]  Sunit K. Singh Human emerging and re-emerging infections / , 2016 .

[16]  E. Kendjo,et al.  The relationship between microfilaraemic and amicrofilaraemic loiasis involving co-infection with Mansonella perstans and clinical symptoms in an exposed population from Gabon , 2015, Journal of Helminthology.

[17]  T. Nutman,et al.  Eosinophil-associated processes underlie differences in clinical presentation of loiasis between temporary residents and those indigenous to Loa-endemic areas. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  B. Mordmüller,et al.  Loa loa-does it deserve to be neglected? , 2014, The Lancet. Infectious diseases.

[19]  D. Bhalla,et al.  Neurological manifestations of filarial infections. , 2013, Handbook of clinical neurology.

[20]  R. Maizels,et al.  Regulatory T Cells in Human Lymphatic Filariasis: Stronger Functional Activity in Microfilaremics , 2012, PLoS neglected tropical diseases.

[21]  B. Ollomo,et al.  Epidemiology of Concomitant Infection Due to Loa loa and Mansonella perstans in Gabon , 2011, PLoS neglected tropical diseases.

[22]  T. Nutman,et al.  Rapid Molecular Assays for Specific Detection and Quantitation of Loa loa Microfilaremia , 2011, PLoS neglected tropical diseases.

[23]  P. Diggle,et al.  The Geographic Distribution of Loa loa in Africa: Results of Large-Scale Implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA) , 2011, PLoS neglected tropical diseases.

[24]  M. Boussinesq,et al.  Case report: Loiasis with peripheral nerve involvement and spleen lesions. , 2011, The American journal of tropical medicine and hygiene.

[25]  A. Hoerauf,et al.  Induction of immunoglobulin G4 in human filariasis: an indicator of immunoregulation , 2010, Annals of tropical medicine and parasitology.

[26]  A. Hoerauf,et al.  Of Mice, Cattle, and Humans: The Immunology and Treatment of River Blindness , 2008, PLoS neglected tropical diseases.

[27]  I. Takougang,et al.  Loiasis — a neglected and under-estimated affliction: endemicity, morbidity and perceptions in eastern Cameroon , 2007, Annals of tropical medicine and parasitology.

[28]  M. Boussinesq Loiasis , 2006, Annals of tropical medicine and parasitology.

[29]  M. Boussinesq,et al.  Loiasis: the individual factors associated with the presence of microfilaraemia , 2005, Annals of tropical medicine and parasitology.

[30]  M. Turner,et al.  Familial eosinophilia: a benign disorder? , 2004, Blood.

[31]  T. Nutman,et al.  The role of eosinophils in host defense against helminth parasites. , 2004, The Journal of allergy and clinical immunology.

[32]  E. Devaney,et al.  Expression of filarial-specific IgG subclasses under different transmission intensities in a region endemic for loiasis. , 2002, The American journal of tropical medicine and hygiene.

[33]  Innocent Takougang,et al.  Rapid assessment method for prevalence and intensity of Loa loa infection. , 2002, Bulletin of the World Health Organization.

[34]  P. Kremsner,et al.  Increased frequency of Th2-type cytokine-producing T cells in microfilaremic loiasis. , 1999, The American journal of tropical medicine and hygiene.

[35]  L. Gibbons Bench Aids for the Diagnosis of Filarial Infections , 1999 .

[36]  C. O. Odigwe,et al.  Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria. , 1998, Acta tropica.

[37]  T. Nutman,et al.  Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation. , 1991, The Journal of infectious diseases.

[38]  B. Carme,et al.  Clinical and biological study of Loa loa filariasis in Congolese. , 1989, The American journal of tropical medicine and hygiene.

[39]  M. Pinder Loa loa - a neglected filaria. , 1988, Parasitology today.

[40]  M. Pinder,et al.  Common occurrence of amicrofilaraemic Loa loa filariasis within the endemic region. , 1988, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[41]  B. Ivanoff,et al.  Filariasis due to Loa loa and Mansonella perstans: distribution in the region of Okondja, Haut-Ogooué Province, Gabon, with parasitological and serological follow-up over one year. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[42]  K. Miller,et al.  Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations. , 1986, The Journal of infectious diseases.